Raras
Buscar doenças, sintomas, genes...
Síndrome de perturbação do desenvolvimento intelectual-dismorfia facial-hipermobilidade articular-perda auditiva
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndromes de blefarofimose e deficiência intelectual são um grupo de doenças genéticas raras que são caracterizadas por blefarofimose, ptose e deficiências intelectuais. Essas doenças geralmente seguem padrões de herança autossômica recessiva, autossômica dominante, recessiva ligada ao X ou mitocondrial.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
5
pacientes catalogados
Herança
Autosomal dominant
+1
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: RJ, PR, RS, ES, PA +5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
11 sintomas
😀
Face
5 sintomas
❤️
Coração
4 sintomas
🦴
Ossos e articulações
4 sintomas
👁️
Olhos
3 sintomas
📏
Crescimento
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

100%prev.
Atraso global do desenvolvimento
Frequência: 11/11
100%prev.
Responsividade social reduzida
Frequência: 6/6
100%prev.
Atraso no desenvolvimento da fala e da linguagem
Frequência: 9/9
100%prev.
Atraso no desenvolvimento motor grosso
Frequência: 10/10
90%prev.
Atraso no desenvolvimento motor fino
Frequência: 9/10
86%prev.
Deficiência intelectual
Frequência: 6/7
40sintomas
Muito frequente (7)
Frequente (13)
Ocasional (16)
Sem dados (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 40 características clínicas mais associadas, ordenadas por frequência.

Atraso global do desenvolvimentoGlobal developmental delay
Frequência: 11/11100%
Responsividade social reduzidaReduced social responsiveness
Frequência: 6/6100%
Atraso no desenvolvimento da fala e da linguagemDelayed speech and language development
Frequência: 9/9100%
Atraso no desenvolvimento motor grossoDelayed gross motor development
Frequência: 10/10100%
Atraso no desenvolvimento motor finoDelayed fine motor development
Frequência: 9/1090%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1
Últimos 10 anos200publicações
Pico2025125 papers
Linha do tempo
2025Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

TET3Methylcytosine dioxygenase TET3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in epigenetic chromatin reprogramming in the zygote following fertilization (PubMed:31928709). Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation (By similarity). Selectiv

LOCALIZAÇÃO

NucleusCytoplasmChromosome

VIAS BIOLÓGICAS (2)
Chromatin modifications during the maternal to zygotic transition (MZT)TET1,2,3 and TDG demethylate DNA
MECANISMO DE DOENÇA

Beck-Fahrner syndrome

A developmental disorder characterized by mild to severe intellectual disability, global developmental delay, hypotonia, autistic traits, movement disorders, growth abnormalities including overgrowth or poor growth, and facial dysmorphism. Both autosomal dominant and autosomal recessive inheritance has been reported.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
27.9 TPM
Skin Sun Exposed Lower leg
27.9 TPM
Linfócitos
24.6 TPM
Cérebro - Hemisfério cerebelar
12.4 TPM
Cerebelo
12.1 TPM
OUTRAS DOENÇAS (1)
Beck-Fahrner syndrome
HGNC:28313UniProt:O43151

Variantes genéticas (ClinVar)

247 variantes patogênicas registradas no ClinVar.

🧬 TET3: NM_001287491.2(TET3):c.3095A>G (p.Tyr1032Cys) ()
🧬 TET3: NM_001287491.2(TET3):c.2212C>T (p.Gln738Ter) ()
🧬 TET3: NM_001287491.2(TET3):c.520T>G (p.Trp174Gly) ()
🧬 TET3: NM_001287491.2(TET3):c.4253G>A (p.Gly1418Asp) ()
🧬 TET3: NM_001287491.2(TET3):c.3212A>C (p.Asp1071Ala) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de perturbação do desenvolvimento intelectual-dismorfia facial-hipermobilidade articular-perda auditiva

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de perturbação do desenvolvimento intelectual-dismorfia facial-hipermobilidade articular-perda auditiva

Centros para Síndrome de perturbação do desenvolvimento intelectual-dismorfia facial-hipermobilidade articular-perda auditiva

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.

Brain &amp; development2026 Mar 20

Angelman syndrome (AS), a rare neurogenetic disorder affecting approximately 1 in 15,000 live births, results from loss of functional UBE3A gene expression and manifests with severe developmental delay, intellectual disability, absent speech, ataxia, epilepsy, and distinctive behavioral features. Until recently, only symptomatic management was available. This review provides pediatric neurologists with a comprehensive, practice-oriented overview of emerging disease-modifying therapies for AS, focusing on therapeutic approaches advancing through clinical development. The molecular pathophysiology of AS, natural history considerations critical for trial interpretation, and the current evidence for antisense oligonucleotide (ASO) therapies (ION582, GTX-102/apazunersen, rugonersen), gene replacement approaches (MVX-220), and next-generation strategies including CRISPR-based gene editing, artificial transcription factors, small molecules, and novel delivery platforms are reviewed. ASO therapies targeting the UBE3A antisense transcript represent the most clinically advanced approach, with three candidates showing proof-of-concept efficacy in Phase 1/2 studies and two advancing to pivotal Phase 3 trials. Gene replacement therapy offers potential single-administration treatment but faces challenges regarding safety, immune responses, and durability. Next-generation approaches including CRISPR activation, epigenetic editing, and blood-brain barrier-penetrating delivery systems show preclinical promise. Critical challenges include outcome measurement limitations, genotype stratification, long-term safety monitoring, and ensuring equitable access. These advances herald a transformation in AS clinical care and represent a milestone in precision pediatric neurology.

#2

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics2026 Mar 16

Biallelic DIAPH1 pathogenic variants cause a neurodevelopmental syndrome occasionally associated with immunodeficiency. This study aims to define the clinical and immunological spectrum of DIAPH1-related neuroimmunological syndrome and explore the gene's developmental role using vertebrate models. 53 individuals with biallelic DIAPH1 variants, including 33 previously unreported patients were studied. Clinical features were analysed and functional studies were conducted using knockout models in Danio rerio and Xenopus tropicalis. Clinical features included developmental delay, intellectual disability, progressive microcephaly, cortical visual impairment or blindness, epilepsy, and frequent occipital-predominant brain abnormalities. Almost half suffered from infections, mainly affecting their respiratory tract related to epilepsy and aspiration. Although the majority had normal lymphocyte subsets and serum immunoglobulins, T-cell receptor excision circles and naïve T-lymphocyte counts were consistently low. The Xenopus model mirrored growth and eye defects seen in humans, while zebrafish exhibited no overt malformations but showed seizure-like behaviour in Phenothiazine assays. DIAPH1 is critical for neurodevelopment, immune regulation, and DNA repair. The DNA repair defect may influence susceptibility to infection, lymphoma, or treatment-related toxicity. Although absolute T-cell numbers are not consistent with SCID, impaired T-cell maturation suggests these patients could be identified by TREC newborn screening before neurological symptoms develop.

#3

Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).

Clinical genetics2026 Mar 20

Biallelic loss-of-function variants in FBXO31 cause autosomal-recessive intellectual disability. A recurrent de novo variant, c.1000G>A(p.Asp334Asn), has been described in association with an autosomal-dominant phenotype. To refine this phenotype and its clinical implications, we re-evaluated three published cases and ascertained four additional probands via advocacy networks, GeneMatcher, and clinician referral. Phenotyping included neurologic, behavioral, and dysmorphology assessment. All seven individuals carried the recurrent de novo FBXO31 p.Asp334Asn variant. A core neurodevelopmental profile was observed and included cerebral palsy (mixed hypotonia, spasticity, and dystonia), global developmental delay/intellectual disability, and speech impairment. Neuropsychiatric features were sometimes prominent and included attention-deficit/hyperactivity disorder, anxiety, stereotypies, autistic features, and behavioral dysregulation. Neuroimaging often showed a hypoplastic corpus callosum and posterior-predominant white-matter changes. In one individual, gray matter heterotopias were also observed. A subtle but consistent facial gestalt was noted. Recurrent FBXO31 p.Asp334Asn variants lead to a recognizable neurodevelopmental syndrome. Based on our findings, we recommend including FBXO31 in diagnostic algorithms for cerebral palsy and neurodevelopmental disorders. We propose the descriptive term "autosomal dominant FBXO31-associated neurodevelopmental disorder," and-consistent with the validating laboratory and with support from the FBXO31 Foundation-propose the eponym "Kruer syndrome."

#4

Znhit3 regulates p53/p21 signaling and governs cerebellar granule cell development.

Cell death and differentiation2026 Mar 19

Mutations in ZNHIT3 are strongly associated with progressive encephalopathy with edema, hypsarrhythmia and optic atrophy (PEHO syndrome), characterized by severe cerebellar atrophy and profound intellectual disability; however, their role in cerebellar development remains unknown. By developing spatiotemporally-regulated conditional Znhit3 knockout mice, we discovered that Znhit3 is essential for granule cell progenitor survival, proliferation, differentiation, and migration. Knockout of Znhit3 caused loss of granule cell progenitors due to apoptosis, premature cell-cycle exit, and migration arrest and resulted in progressive anterior-lobe atrophy and motor deficits. The granule cell progenitor-autonomous defects secondarily impaired Purkinje cell alignment, dendritic maturation, and synaptic organization. Transcriptomic analyses revealed activation of the p53/p21 pathway, rRNA processing defects, and nucleolar stress. Genetic or pharmacologic inhibition of p53/p21 signaling rescued granule cell progenitor development and restored cerebellar architecture in the Znhit3-knockout mice. Thus, ZNHIT3 is a critical regulator of ribosome biogenesis and cerebellar growth, suggesting nucleolar stress-p53/p21 signaling as a potential therapeutic target in ZNHIT3-related disorders.

#5

Tuberous sclerosis complex.

Nature reviews. Disease primers2026 Mar 12

Tuberous sclerosis complex (TSC) is a rare genetic disease caused by heterozygous loss-of-function variants in TSC1 or TSC2. Patients present with benign tumours known as hamartomas in the brain, eyes, lungs, kidneys, heart and skin. Many hamartomas contain mosaic second hit variants in TSC1 or TSC2. The most disabling features of TSC include epilepsy and TSC-associated neuropsychiatric disorders (TAND) such as intellectual disability and autism spectrum disorder. Remarkable progress has been made both in understanding the pathogenesis of TSC and in its clinical management, largely due to the discovery of the link between TSC1 and TSC2 and the mechanistic target of rapamycin (mTOR) signalling pathway. TSC1 and TSC2 form a protein complex that inhibits mTOR. Naturally occurring inhibitors of mTOR (rapamycin) and its analogues, collectively known as rapalogues, have been used to test various hypotheses in preclinical models and are approved for the treatment of several manifestations of TSC. Approved drug treatments (rapalogues) exist for subependymal giant cell astrocytomas, renal angiomyolipomas, pulmonary lymphangioleiomyomatosis, facial angiofibromas and refractory seizures. However, there is still an unmet need for effective treatment of TAND and refractory epilepsy, despite the available medical and surgical options.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.

Brain &amp; development
2026

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).

Clinical genetics
2026

Znhit3 regulates p53/p21 signaling and governs cerebellar granule cell development.

Cell death and differentiation
2026

Contribution of astrocytic calcium signaling to auditory hypersensitivity in a mouse model of fragile X syndrome.

Neurobiology of disease
2026

The disproportionate burden of severe obesity in youth with special needs and the role of metabolic and bariatric surgery.

Seminars in pediatric surgery
2026

Biallelic Novel SKOR2 Variants in Individuals With Cerebellar Hypoplasia and Intellectual Disability, Expanding the Phenotypic Spectrum of Valence-Farazi Cerebellar Ataxia Syndrome.

American journal of medical genetics. Part A
2026

Tuberous sclerosis complex.

Nature reviews. Disease primers
2026

Novel ANKRD11 Mutation in KBG Syndrome: A diagnostic triad of hearing loss, radiological macrodontia and artificial intelligence-assisted facial phenotyping.

Sultan Qaboos University medical journal
2026

Stimulation of the medial septum diagonal band of broca rescues learning and memory deficits in Fmr1 KO mice.

iScience
2026

De Novo 3q27.1 Microdeletion Refines the Critical Region and Implicates PSMD2 Haploinsufficiency in Growth and Neurodevelopmental Abnormalities.

American journal of medical genetics. Part A
2026

Dental Implants in Adults With Intellectual Disabilities: A Multicenter Retrospective Study. Part 1: Implant Outcomes.

Journal of oral rehabilitation
2026

WDTC1 Haploinsufficiency as a Cause of Neurodevelopmental Phenotypes.

Clinical genetics
2026

PRPS1 (p.V42L) Mutation in Arts Syndrome Induces Aberrant Neural Stem Cell Development and Neuronal Senescence-Like Phenotype: Rescue by Nicotinamide Mononucleotide Supplementation.

International journal of stem cells
2026

Calcium release channel deficiency syndrome in patients diagnosed with idiopathic ventricular fibrillation and decedents classified as sudden unexplained death in the young.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2026

Uncovering targets and molecular pathways for personalizing treatment in epilepsy.

Expert opinion on therapeutic targets
2026

Medicaid home and community based services are vital for adults with intellectual and developmental disabilities: A descriptive study of service use among all adult enrollees, 2022.

Disability and health journal
2026

Transcriptome analysis of patients with loss-of-function POGZ variants in four unrelated Chinese families.

Gene
2026

Cognitive, Behavioral, and Emotional Manifestations in Nodding Syndrome: A Neuropsychological Narrative Review.

Revista de neurologia
2026

Correlations between phenotype and gene region-specific episignatures in Rubinstein-Taybi syndrome and Menke-Hennekam syndrome.

Human molecular genetics
2026

Neuroradiological Phenotype Expansion of the Siddiqi Syndrome: A Case Report.

Cellular and molecular neurobiology
2026

Neurocardiogenetics: Exploring the association of rare RYR2 variants with neuropsychiatric disorders in general and disease populations.

Journal of neurogenetics
2026

Case Report: A female case of X-linked intellectual disability syndrome type 34 caused by a NONO frameshift variant and literature review.

Frontiers in pediatrics
2026

Input-and cell-type-specific developmental alterations to thalamic synapses in a Dravet syndrome mouse model.

bioRxiv : the preprint server for biology
2026

De novo mutation in the ARHGAP32 gene endorses the implication of GTPase-activating proteins (RhoGAP family) in idiopathic autism spectrum disorder.

Frontiers in psychiatry
2026

Novel Mutations in KCNJ10 Gene Associated With SeSAME Syndrome: Rare Disorder With Possible Common Mutation.

Molecular genetics &amp; genomic medicine
2026

Altered Brain Structure in an ATRX-Deficient Mouse Model of Autism Spectrum Disorder.

Autism research : official journal of the International Society for Autism Research
2026

Neuronal Heterotopy in a Patient with Wiedemann-Steiner Syndrome Caused by a Truncating KMT2A Variant: Clinical and Genetic Correlations.

Reports (MDPI)
2026

Up-regulation of Minibrain/DYRK1A contributes to macrocephaly and brain overgrowth in a Drosophila model of fragile X syndrome.

Proceedings of the National Academy of Sciences of the United States of America
2026

First Report of a Child With a DeSanto-Shinawi Syndrome and a Polymorphous Low-Grade Neuroepithelial Tumor of the Young.

American journal of medical genetics. Part A
2026

Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2026

Novel VARS1 variants define new clinical and molecular subtypes of a rare neurodevelopmental syndrome.

Biochimica et biophysica acta. Molecular basis of disease
2026

Management of Pathological Dental Attrition in Prader-Willi Syndrome: A Case Report Using the Personalized Radboud Strategy.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2026

UBE3A isoform-selective and non-selective contributions to Angelman syndrome phenotypes.

Molecular psychiatry
2026

GABAB Receptor signaling in CA1 Pyramidal Cells is not Regulated by Aging in the APP/PS1 Mouse Model of Amyloid Pathology.

eNeuro
2026

Hippocampal glial alterations are associated with Lamin B1 dysregulation and abnormal nuclear morphology in a rat model of fragile X syndrome.

Neurobiology of disease
2026

Bi-allelic loss-of-function variants in JKAMP cause a neurodevelopmental syndrome associated with dysregulation of GPR37 trafficking.

American journal of human genetics
2026

Loss of Zmiz1 in Mice Leads to Impaired Cortical Development and Autistic-Like Behaviors.

Biological psychiatry
2026

Type 2 Diabetes in a Portuguese Adolescent With Hijazi-Reis Syndrome.

Cureus
2026

A Patient With Intellectual Disability, Agenesis of Corpus Callosum, and Congenital Heart Disease Associated With Chromosome 10p11.2 Microdeletion.

American journal of medical genetics. Part A
2026

UBTF Haploinsufficiency-Related Disorder: Report of a New Case Series and Definition of the Facial Gestalt.

Clinical genetics
2026

Beyond Neurodevelopmental Delay: BICRA-Related Coffin-Siris Syndrome 12 with Severe Intestinal Dysmotility and Recurrent Pneumothorax.

Genes
2026

Prenatal Diagnosis of Radio-Tartaglia Syndrome Caused by a Loss-of-Function Variant in SPEN in a Chinese Family.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2025

AAV-mediated neuronal expression of FOXG1 restores oligodendrocyte maturation, myelination, and hippocampal structure in mouse models of FOXG1 syndrome.

bioRxiv : the preprint server for biology
2026

Expanding the Phenotypic Spectrum Associated With Loss-of-Function SMARCA4 Variants to Eye Developmental Anomalies.

Clinical genetics
2026

Cowden Syndrome in Childhood: Gastrointestinal Involvement in a Multisystem Genetic Disorder-A Case Report.

Reports (MDPI)
2025

Intellectual Developmental Disorder of Autosomal Dominant 61 Caused by a MED13 Variant Presenting With Congenital Unilateral Sensorineural Hearing Loss: A Case Report.

Cureus
2026

Olfactory Deficits in Fragile X Syndrome.

The European journal of neuroscience
2026

Alpha-mannosidosis due to a novel MAN2B1 truncating mutation in a Chinese patient: a new report and long-term follow-up.

Documenta ophthalmologica. Advances in ophthalmology
2026

A novel CLPP variant in a Pakistani family with Perrault syndrome associated with recurrent fevers.

Clinica chimica acta; international journal of clinical chemistry
2026

The missense mutation Y65C in PQBP1 causes microcephaly and cognitive deficits through a combination of partial loss-of-function and gain-of-function effects.

Nature communications
2026

Temporal transcriptomic changes during neurodevelopment in a mouse model of Smith-Lemli-Opitz syndrome.

The Journal of steroid biochemistry and molecular biology
2025

De novo MAP2K4 variants cause a novel neurodevelopmental syndrome with impaired JNK signaling in iPSC-derived neurons.

medRxiv : the preprint server for health sciences
2025

Measuring economic burden in families of individuals with Angelman Syndrome in Poland: a caregivers' survey.

Orphanet journal of rare diseases
2026

De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.

American journal of human genetics
2025

Spinocerebellar ataxia, autosomal recessive type 23 (SCAR23) with compound TDP2 variants: clinical, molecular, and quantitative follow-up.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

A pediatric case of diphthamide biosynthesis 1 gene defect presenting with developmental delay, short stature, dysmorphic features, and sparse hair (Loucks-Innes syndrome): a case report.

Journal of medical case reports
2025

Chinese clinical practice guidelines for super minimally invasive surgery of digestive tract tumors.

Journal of translational internal medicine
2025

VPS13B recruits lipid vesicles to promote mitochondrial fission and quality control.

Nature communications
2026

Altered Auditory Maturation in Fragile X Syndrome and Its Involvement in Audiogenic Seizure Susceptibility.

Autism research : official journal of the International Society for Autism Research
2025

Sexual Health and Transition Needs in an Adolescent Girl With Attention-deficit Hyperactivity Disorder and Smith-magenis Syndrome.

Journal of developmental and behavioral pediatrics : JDBP
2025

Tatton-Brown-Rahman Syndrome Due to a Novel DNMT3A Variant Presenting With Autism, Attention-Deficit/Hyperactivity Disorder (ADHD), and Regression: A Saudi Case Report.

Cureus
2025

A Novel SIL1 Variant (p.E342K) Associated with Marinesco-Sjögren Syndrome Impairs Protein Stability and Function.

International journal of molecular sciences
2026

Doublecortin-expressing cells are selectively altered in the piriform cortex but not in neurogenic areas of symptomatic Mecp2-heterozygous mice.

Neuroscience
2025

Anesthetic Management of a Patient With Myhre Syndrome.

Anesthesia progress
2025

Five novel EP300 variants expand the genetic and phenotypic spectrum of Rubinstein-Taybi syndrome type 2 in Chinese patients.

Frontiers in genetics
2025

Rare co-existence of 15q26 deletion syndrome and lymphangioleiomyomatosis: diagnostic and therapeutic challenge.

Journal of applied genetics
2026

Modeling Mowat-Wilson syndrome with patient iPSCs reveals transcriptional and phenotypic defects in neural progenitors.

Neurobiology of disease
2025

Delayed onset of striatal projection neuron hyperexcitability in Fmr1-/y mice.

Frontiers in cellular neuroscience
2026

Revisiting Wiedemann-Steiner Syndrome: Novel KMT2A Variants and Broadened Clinical Spectrum.

Balkan medical journal
2025

Altered Short Non-Coding RNA Landscape in the Hippocampus of a Mouse Model of CDKL5 Deficiency Disorder.

Biomolecules
2025

A Novel STAG2 Frameshift Variant in Mullegama-Klein-Martinez Syndrome with Complex Conotruncal Heart Defect.

Genes
2026

The Bounce-back Effect: What Happens After Cessation of Low-dose Semaglutide in People With HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2026

Expanding the Phenotype of Syndromic SLC30A9 -Associated Disease.

American journal of medical genetics. Part A
2025

Effects of Metformin on children with Fragile X Syndrome: a randomized, double-blind, placebo-controlled trial.

Molecular autism
2025

Long-read sequencing identifies a novel de novo inversion in SMARCC2 in a pediatric patient with Coffin-siris syndrome 8: a case report.

BMC medical genomics
2025

ZMYND11 Restrains KMT2A to Enable a Neuronal Developmental Program.

bioRxiv : the preprint server for biology
2025

Ganaxolone, an approved therapy for CDKL5-Deficiency Disorder, is an inhibitor of PTP1B.

bioRxiv : the preprint server for biology
2025

JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food Intake.

bioRxiv : the preprint server for biology
2025

Bi-allelic PRMT9 loss-of-function variants cause a syndromic form of intellectual disability.

American journal of human genetics
2025

WDR81 Mutation in Two Siblings: A Case Report and Review of Literature.

Molecular syndromology
2025

Bilateral Testicular Regression Syndrome and Optic Nerve Atrophy: Clinical Aspects of a Child with a <italic>SEMA3E</italic> Loss-of-Function Variant.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2025

A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.

Molecular biology reports
2026

Astrocytic Chromatin Remodeler ATRX Gates Hippocampal Memory Consolidation Through Metabolic and Synaptic Regulation.

Glia
2026

Nance-Horan Syndrome: Further Delineation of the Affected Male and the Female Carrier Phenotypes.

American journal of medical genetics. Part A
2025

Expanding the Phenotype Spectrum of β-Mannosidosis.

Neurology. Genetics
2025

Descriptive Epidemiology From the Myhre Syndrome Foundation Registry: The Value of Self-Reported Data.

American journal of medical genetics. Part C, Seminars in medical genetics
2025

Two Chinese patients with Basilicata-Akhtar syndrome caused by novel MSL3 variants: a case report and literature review.

Translational pediatrics
2025

Gene Therapy for Fragile X Syndrome, Challenges, and Promises.

The journal of gene medicine
2026

Identification of a novel de novo NONO variants causing X-linked syndromic intellectual developmental disorder-34 in a fetus.

European journal of obstetrics, gynecology, and reproductive biology
2025

First Report of a Familiar MYCBP2 Pathogenic Variant: Expanding the Knowledge of Neurodevelopmental Disorders.

Balkan journal of medical genetics : BJMG
2025

KCNT1 (Slack/Slo2.2) and KCNT2 (Slick/Slo2.1) Dysregulation in Intellectual Disability and Behavioral Phenotypes: A Systematic Review.

Cureus
2025

Aberrant hippocampal gamma oscillations in a mouse model of fragile X syndrome: insights from in vitro slice models.

Molecular autism
2025

Spermine synthase in Snyder-Robinson syndrome and cancer.

Molecular biology reports
2025

ADNP Exhibits Methyltransferase Activity in Overexpression Systems and Modulates DNA and Histone Methylation.

Autism research : official journal of the International Society for Autism Research
2025

In-depth behavioral characterization of a rat model of Schaaf-Yang syndrome.

Scientific reports
2025

The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder.

Pharmaceuticals (Basel, Switzerland)
2025

Rubinstein-Taybi Syndrome: A Comprehensive Analysis of a Polish Cohort with Most Cases Due to Novel CREBBP and EP300 Variants.

Genes
2025

Bridging Genotype to Phenotype in KMT5B-Related Syndrome: Evidence from RNA-Seq, 18FDG-PET, Clinical Deep Phenotyping in Two New Cases, and a Literature Review.

Genes
2025

A Case Report: Co-Occurrence of TNRC6B Gene Variant and Xq28 Microdeletion Syndrome With Comprehensive Literature Review.

Birth defects research
2025

The first description of CTNNB1 syndrome in the Tunisian population: clinical investigation, molecular docking and molecular dynamics simulation of β-catenin/E-cadherin complex.

Molecular biology reports
2025

A Novel Variant in the BICRA Gene, Expanding the Phenotype: A Case Report.

Case reports in genetics
2025

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

American journal of human genetics
2026

Functional Characterization of a Novel GPC3 Missense Variant in Simpson-Golabi-Behmel Syndrome.

American journal of medical genetics. Part A
2026

Screen time in children with neurodevelopmental disorders and their parents: a survey-based study in a paediatric Italian sample.

Disability and rehabilitation. Assistive technology
2026

Genomic Testing in Australia: A Budget Impact Analysis Using Diffusion Modeling From a Healthcare System Perspective.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2026

Removing Barriers to Bariatric Surgery: The Role of Intellectual and Developmental Disabilities on Outcomes in Adolescents and Young Adults.

Clinical obesity
2026

A 2-year-old girl with merged phenotypes: galactosemia and Coffin-Lowry syndrome.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2026

De Novo Heterozygous ZFX Frameshift Variant in a Female With an X-Linked Neurodevelopmental Disorder.

American journal of medical genetics. Part A
2025

Developmental arrest of astrocyte lineage in Snai2 deletion mice: implication for the intellectual disability in patients with Waardenburg syndrome.

Translational psychiatry
2025

SETBP1 variants outside the degron disrupt DNA-binding, transcription and neuronal differentiation capacity to cause a heterogeneous neurodevelopmental disorder.

Nature communications
2025

Biallelic NDUFA9 variants cause a progressive neurodevelopmental disorder with prominent dystonia and mitochondrial complex I deficiency.

Brain communications
2025

A Novel Intragenic Duplication of CREBBP in Rubinstein-Taybi Syndrome: A Case Report Expanding the Genotype-Phenotype Spectrum.

Molecular syndromology
2025

New Pathogenic Variant in the GLI3 Gene in the First Colombian Patient Associated With Pallister-Hall Syndrome: A Clinical Report.

Molecular genetics &amp; genomic medicine
2025

ACTB deletions or single-nucleotide loss-of-function variants: expansion and further delineation of the phenotype and review of the literature.

Journal of medical genetics
2025

Clinical and molecular findings of KMT2D-related Kabuki syndrome: A series of 13 patients with 3 novel variants.

European journal of medical genetics
2025

CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice.

Science translational medicine
2025

Homozygous PGAP2 Mutation Causes Hyperphosphatasia with Mental Retardation Syndrome-3: Genetic and Clinical Evaluation of the Ultra-Rare Inherited Glycosylphosphatidylinositol Biosynthesis Defect.

Molecular syndromology
2025

Multidimensional Characterisation of Eating Behaviour in Genetic Obesity: A Systematic Review.

Obesity facts
2025

Courtship and distress ultrasonic vocalizations are altered in a mouse model of Angelman syndrome.

Journal of neurodevelopmental disorders
2025

Zscan4 as a Candidate Conveyor of Early Developmental Defects in O-GlcNAc Transferase Intellectual Disability.

Molecular &amp; cellular proteomics : MCP
2025

Rare features in Feingold syndrome type 1.

European journal of medical genetics
2025

Probing DNA damage in Rett syndrome neurons uncovers a role for MECP2 regulation of PARP1.

Stem cell reports
2025

FX ENTRAIN: scientific context, study design, and biomarker driven brain-computer interfaces in neurodevelopmental conditions.

Frontiers in neuroscience
2025

Normalization of network activity in an epilepsy model with a constitutively active GABBR2 variant.

Brain : a journal of neurology
2025

Further phenotypical delineation of DLG3-related neurodevelopmental disorders.

European journal of human genetics : EJHG
2025

Optimized in vivo base editing restores auditory function in a DFNA15 mouse model.

Nature communications
2025

PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia.

The Journal of clinical investigation
2025

Human Neuron and Mouse Models Reveal Synaptic Imbalance in Kabuki Syndrome.

bioRxiv : the preprint server for biology
2025

A Novel Frameshift Variant in the hnRNPK Gene Associated with Au-Kline Syndrome Identified During Prenatal Diagnosis: A Case Report.

Annals of clinical and laboratory science
2026

Two Siblings With Al Kaissi Syndrome: Clinical, Radiological, and Molecular Characterization of Compound Heterozygous CDK10 Variants.

American journal of medical genetics. Part A
2025

In utero rescue of neurological dysfunction in a mouse model of Wiedemann-Steiner syndrome.

JCI insight
2025

Novel neuropathological observations in an adult with Dravet syndrome.

Epilepsia
2026

Prenatal Diagnosis of MSL2-Related Ventriculomegaly in Association With an Inherited 15q13 Microduplication.

Clinical genetics
2025

Novel variants in ZNF462 and phenotype update in patients with Weiss-Kruszka syndrome: a case series.

Translational pediatrics
2025

Chromosome 15q Structural Variants Associated with Syndromic Autism Spectrum Disorder: Clinical and Genomic Insights from Three Case Reports in a Brazilian Reference Center.

International journal of molecular sciences
2026

Identification of a Non-Coding Causative Variant Underlying Warsaw Breakage Syndrome Using Long-Read Based Genomic Sequencing and Transcriptome Analysis.

American journal of medical genetics. Part A
2025

The role of resistance training in mitigating cancer-induced cachexia: A systematic review.

Sports medicine and health science
2025

Test-Retest Reliability and Variability Over Time for Repeated Audiometric Assessment in Individuals With Down Syndrome.

American journal of audiology
2025

Deletion of the SHORT Syndrome Gene Prkce Results in Brain Atrophy and Cognitive and Motor Behavior Deficits in Mice.

Neuroscience bulletin
2025

Exaggerated NMDA Receptor-Primed Metaplasticity via SK Channel Dysregulation in Fmr1 Knockout Mice.

bioRxiv : the preprint server for biology
2025

A 17-year-old female with Down syndrome and Crohn's disease: a rare case report from Syria.

Annals of medicine and surgery (2012)
2025

Benefits of Maternal Choline Supplementation on Aged Basal Forebrain Cholinergic Neurons (BFCNs) in a Mouse Model of Down Syndrome and Alzheimer's Disease.

Biomolecules
2026

Loss of Necdin causes social deficit and aberrant synaptic function through destabilization of SynGAP.

Molecular psychiatry
2025

Severe Elimination Disorders and Normal Intelligence in a Case of MAP1B Related Syndrome: A Case Report.

Genes
2025

Bi-Allelic Loss-of-Function Variant in MAN1B1 Cause Rafiq Syndrome and Developmental Delay.

International journal of molecular sciences
2025

Case Report: Identification of a novel hemizygous missense RPL10 gene variant in two unrelated patients.

Frontiers in pediatrics
2025

Identification of a novel, pathogenic CREBBP variant in a patient with Menke-Hennekam syndrome: a Case Report.

Frontiers in genetics
2025

Dominant-negative effects of Weaver syndrome-associated EZH2 variants.

Genes &amp; development
2026

Case Series of Nizon-Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid-Triploid Mosaicism.

American journal of medical genetics. Part A
2025

State-of-the-art management of Dravet syndrome.

Developmental medicine and child neurology
2025

The NuRD component CHD3 promotes BMP signalling during cranial neural crest cell specification.

EMBO reports
2025

Reduced Muscle Loss in Patients With NSCLC Taking Fibrates: Findings From a Retrospective Observational Study.

Journal of cachexia, sarcopenia and muscle
2025

A Coffin-Siris syndrome-associated mutation modeled in Caenorhabditis elegans affects multiple developmental processes.

G3 (Bethesda, Md.)
2025

WDR26-related Skraban-Deardorff syndrome: clinical, genetic and pathomechanistic insights.

European journal of medical research
2025

RAB23 loss-of-function mutation causes context-dependent ciliopathy in Carpenter syndrome.

PLoS genetics
2026

Functional Characterization of Two Novel Biallelic PIGV Variants in a Patient With Myoclonic Seizures and Elevated Alkaline Phosphatase: A Case Report.

American journal of medical genetics. Part A
2025

SMARCB1-related schwannomatosis and other SMARCB1-associated phenotypes: clinical spectrum and molecular pathogenesis.

Familial cancer
2025

Clinically Meaningful Reduction in Drop Seizures in Patients with Lennox-Gastaut Syndrome Treated with Cannabidiol: Post Hoc Analysis of Phase 3 Clinical Trials.

CNS drugs
2025

Prolonged Follow-Up in a 30-Year-Old Male With a Novel Pathogenic Variant in MSL3 : A Case Report and a Brief Review of the Literature.

American journal of medical genetics. Part A
2025

Restoring DSCAM expression rescues neuronal morphology and axon guidance deficits in Down syndrome.

bioRxiv : the preprint server for biology
2025

Case report of paroxysmal dystonia in a child with KBG syndrome: Expansion of the phenotype and utility of whole exome sequencing.

Medicine
2025

Expanding the Clinical Phenotype Associated with the NIN Gene; Report of a Patient with Short Stature, Microcephaly and Hearing Loss.

Archives of Iranian medicine
2025

c.7156C > T p.(Gln2386*) variant causes loss-of-function of the USP9X gene in a female-restricted X-linked syndromic intellectual disability: a case report.

Journal of medical case reports
2025

β-Actin Deficiency in Baraitser-Winter Syndrome Type 1 Disrupts T-Cell Function and Immune Regulation: Implications for Targeted Therapy in Actinopathies.

Journal of clinical immunology
2025

FMRP-dependent translational control negatively regulates adapter protein complex 2-mediated endocytosis.

iScience
2025

A survey of hypothalamic phenotypes identifies molecular and behavioral consequences of MYT1L haploinsufficiency in male and female mice.

Hormones and behavior
2025

Expanding the Phenotypic Spectrum Associated with DPH5-Related Diphthamide Deficiency.

Genes
2025

A 261 kb deletion spanning three genes is causing Rubinstein-Taybi syndrome type 1 in a 6-year-old boy belonging to Kashmir valley, India.

Gene
2025

Effects of SLC6A8 mutation-induced creatine deficiency on cellular function in fibroblasts.

Scientific reports
2025

Ocular Manifestations in Congenital Insensitivity to Pain with Anhidrosis: A Window into a Rare Syndrome.

Vision (Basel, Switzerland)
2025

Hypotrichosis 14: novel variants of the LSS gene in five Chinese families and insights from literature review.

Human genomics
2026

FMRP regulation of STAT3-MYC signaling is critical for adult hippocampal neurogenesis and cognitive flexibility.

Cell death and differentiation
2025

Tatton-Brown-Rahman-Syndrome-associated DNMT3A mutations de-repress cortical interneuron differentiation to disrupt neuronal network function.

bioRxiv : the preprint server for biology
2025

Late onset of striatal projection neuron hyperexcitability in Fmr1 -/y mice.

bioRxiv : the preprint server for biology
2025

FBRSL1 regulates the expression of chromatin regulators BRPF1 and KAT6A.

Human genetics
2025

A Novel SON Gene Variant Associated with Rare Clinical Features in ZTTK Syndrome: A Case Report and Literature Review.

Molecular syndromology
2025

Case Report: Diagnostic assessment, developmental trajectory and treatment approaches in a case of a complex neurodevelopmental syndrome associated with non- synonymous variants in MECP2 (p. R133C) and GABBR1.

Frontiers in pediatrics
2025

Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome.

Nature communications
2025

Developmental and Epileptic Encephalopathy as a Novel Clinical Hallmark of SCA21.

Neuropediatrics
2025

A novel TIMM8A mutation in Mohr-Tranebjaerg syndrome without hearing loss and with basal ganglia iron deposition.

Orphanet journal of rare diseases
2025

EGR3 Deletion Rescues Developmental and Epileptic Encephalopathy in Kcna1-null Mice.

bioRxiv : the preprint server for biology
2025

Persistent hypokalemia due to Conn's syndrome resolved by robot-assisted laparoscopic adrenalectomy. A correct diagnostic approach for proper surgical therapy. Case report.

Journal of surgical case reports
2025

[Cohen syndrome in a child caused by compound heterozygous variants in VPS13B gene].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

A novel heterozygous mutation of ANKRD11 causes KBG syndrome in a preterm neonate: a case report and literature review.

Frontiers in pediatrics
2025

Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial.

Nutrients
2025

Comprehensive analysis of CNOT3-related neurodevelopmental disorders: phenotypic and genotypic characterization.

European journal of human genetics : EJHG
2025

Functional analysis of human EED variants using Drosophila.

Genetics
2025

A novel homozygous missense DNAJC3 variant in syndromic juvenile-onset diabetes.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Association of genetic variants, protein domains, and phenotypes in the ZMIZ1 syndromic neurodevelopmental disorder.

Frontiers in neuroscience
2025

Altered Microglial Plasticity in the Periaqueductal Grey of Pre-Symptomatic Mecp2-Heterozygous Mice Following Early-Life Stress.

Neuromolecular medicine
2025

A Japanese Case of Lenz-Majewski Syndrome With a Novel PTDSS1 Variant.

Molecular genetics &amp; genomic medicine
2026

First Report of a Novel Pathogenic Variant in the RREB1 Gene Associated With Obesity and Metabolic Syndrome.

Clinical genetics
2025

The role of Goldilocks protein kinase DYRK1A in embryonic development.

Developmental biology
2025

Early-Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B.

Movement disorders : official journal of the Movement Disorder Society
2025

Lifting Limits: The Impact of Strength Training in Down Syndrome-A Systematic Review and Meta-Analysis.

Journal of intellectual disability research : JIDR
2025

Clinical variability in individuals with ATR-X syndrome in the Netherlands.

European journal of medical genetics
2026

The genetic and phenotypic spectrum of GABRB1-related disorders.

Brain : a journal of neurology
2025

Dyggve-Melchior-Clausen Syndrome in Ecuador: Expanding Knowledge on a Rare Genetic Disorder.

Genes
2025

Unraveling Glypican-3: From Structural to Pathophysiological Roles and Mechanisms-An Integrative Perspective.

Cells

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de perturbação do desenvolvimento intelectual-dismorfia facial-hipermobilidade articular-perda auditiva.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de perturbação do desenvolvimento intelectual-dismorfia facial-hipermobilidade articular-perda auditiva

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.
    Brain &amp; development· 2026· PMID 41864145mais citado
  2. Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.
    Genetics in medicine : official journal of the American College of Medical Genetics· 2026· PMID 41860019mais citado
  3. Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).
    Clinical genetics· 2026· PMID 41858232mais citado
  4. Znhit3 regulates p53/p21 signaling and governs cerebellar granule cell development.
    Cell death and differentiation· 2026· PMID 41857137mais citado
  5. Tuberous sclerosis complex.
    Nature reviews. Disease primers· 2026· PMID 41820375mais citado
  6. De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.
    Am J Hum Genet· 2026· PMID 41468891recente
  7. Bi-allelic PRMT9 loss-of-function variants cause a syndromic form of intellectual disability.
    Am J Hum Genet· 2025· PMID 41260215recente
  8. Bilateral Testicular Regression Syndrome and Optic Nerve Atrophy: Clinical Aspects of a Child with a SEMA3E Loss-of-Function Variant.
    Sex Dev· 2025· PMID 41243476recente
  9. A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.
    Mol Biol Rep· 2025· PMID 41240171recente
  10. The first description of CTNNB1 syndrome in the Tunisian population: clinical investigation, molecular docking and molecular dynamics simulation of β-catenin/E-cadherin complex.
    Mol Biol Rep· 2025· PMID 41137963recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:684216(Orphanet)
  2. OMIM OMIM:618798(OMIM)
  3. MONDO:0032922(MONDO)
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q120973015(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de perturbação do desenvolvimento intelectual-dismorfia facial-hipermobilidade articular-perda auditiva

ORPHA:684216 · MONDO:0032922
Prevalência
<1 / 1 000 000
Casos
5 casos conhecidos
Herança
Autosomal dominant, Autosomal recessive
Prevalência
0.0 (Worldwide)
MedGen
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades